Form 4: FactSet Executive Christopher R. Ellis Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Christopher R. Ellis, an EVP at FactSet Research Systems, reported the exercise of stock options and the sale of common stock on September 26, 2024.

Summary

  • On September 26, 2024, Christopher R. Ellis, an Executive Vice President at FactSet Research Systems, executed transactions involving FactSet's common stock.
  • Ellis exercised stock options to acquire 7,577 shares at $165.37 and 6,375 shares at $175.2.
  • He then sold 13,952 shares at $456.15.
  • Following these transactions, Ellis directly owns 23,514.6867 shares of FactSet common stock and indirectly owns 450 shares through his spouse.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand management's perspective on the company's stock.

Comparison to Industry Standards

  • Executive stock option exercises and sales are common across publicly traded companies.
  • The specific details of vesting schedules and option pricing are company-specific and depend on the compensation packages offered to executives.
  • Comparing Ellis's transactions to those of executives at similar financial data and software companies (e.g., Bloomberg, MSCI, S&P Global) would provide a broader context, but that data is not available in this document.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.
  • There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
10/16/2015Date options were granted that vest 40% on the second anniversary and then ratably at 20% per year over three years.
11/02/2015Date options were granted that vest 20% annually on the anniversary date and are fully vested after five years.
09/26/2024Date of the reported transactions: exercising stock options and selling shares.
09/27/2024Date of signature on the Form 4 filing.
10/16/2025Expiration date for some of the employee stock options.
11/02/2025Expiration date for some of the employee stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.